Clinical Scorecard: Implementation and Outcomes of a Comprehensive Screening Initiative for HIV, HBV, and HCV in an Emergency Department Setting

At a Glance

Key Highlights

• Late diagnosis of HIV remains a critical barrier; approximately one-third of new HIV diagnoses in Berlin present with advanced disease.
• Universal opt-in BBV screening in emergency departments can identify undiagnosed infections, especially in high-prevalence urban settings.
• Comprehensive patient education and multilingual consent processes facilitate screening uptake.

Guideline-Based Recommendations

Diagnosis

• Implement routine HIV screening for patients aged 13-64 in high-prevalence settings as per CDC recommendations.
• Use universal opt-in screening in emergency departments to increase case detection beyond risk-based testing.
• Exclude patients unable or unwilling to consent and those with occupational injuries from screening.

Management

• Initiate timely therapy upon diagnosis to improve individual outcomes and reduce transmission.
• Provide patient education and counseling prior to testing to ensure informed consent.

Monitoring & Follow-up

• Track late diagnosis rates using CD4 counts and AIDS-defining conditions.
• Monitor screening uptake and prevalence rates within emergency department populations.

Risks

• Risk-based testing alone misses asymptomatic infections and late diagnoses.
• Structural barriers may limit access to diagnostics and treatment, requiring targeted outreach.

Patient & Prescribing Data

Emergency department patients aged 18-68 undergoing blood sampling in Berlin

Early diagnosis through universal screening enables timely initiation of antiretroviral or antiviral therapy, improving outcomes and reducing transmission risk.

Clinical Best Practices

• Adopt universal opt-in BBV screening in emergency departments serving high-prevalence urban populations.
• Provide multilingual educational materials and consent forms to accommodate diverse patient populations.
• Train nursing staff in patient education and counseling to support informed consent and testing uptake.

References

• UNAIDS 95-95-95 Targets
• WHO Global Health Sector Strategy on Viral Hepatitis
• CDC Recommendations for HIV Screening
• Robert Koch Institut HIV Data
• Berlin HIV Epidemiology